𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mucoepidermoid carcinoma of the parotid as a second malignant neoplasm in children

✍ Scribed by Timothy S. Loy; Richard McLaughlin; Lorrie F. Odom; Louis P. Dehner

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
552 KB
Volume
64
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Mucoepidermoid carcinoma of salivary gla
Mucoepidermoid carcinoma of salivary glands in the pediatric age group: 18 clinical cases, including 11 second malignant neoplasms
✍ Pierre Olivier VΓ©drine; Laurent Coffinet; StΓ©phane Temam; Karine Montagne; Miche πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

## Abstract ## Background. Salivary gland tumors represent 1% of head and neck tumors, with only 5% of these occurring in patients younger than 20 years. Mucoepidermoid carcinoma (MEC) is one of the most frequent salivary gland cancers among adults and children. ## Methods. This survey was condu

Bone sarcoma as a second malignant neopl
Bone sarcoma as a second malignant neoplasm in children: Influence of radiation and genetic predisposition
✍ Anna T. Meadows; Louise C. Strong; Frederick P. Li; Giulio J. D'Angio; Odile Sch πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 384 KB πŸ‘ 2 views

Osteosarcoma or chondrosarcoma developed as a second malignant neoplasm (SMN) in 40 of 188 individuals with SMN whose first neoplasm occurred in childhood. A genetic susceptibility to cancer was found in 23; the SMN developed in an irradiated field in 32; both factors were present in 16; neither in

Soft tissue sarcoma as a second malignan
Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group
✍ Gianni Bisogno; Guido Sotti; Yohann Nowicki; Andrea Ferrari; Alberto Garaventa; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Survivors of childhood malignancies have an increased risk of developing second malignant neoplasms (SMN) due to their prior treatment and/or genetic susceptibility. A small proportion of SMNs are soft tissue sarcomas (STS), whose prognosis is generally thought to be poor